Literature DB >> 26398623

PharmGKB summary: succinylcholine pathway, pharmacokinetics/pharmacodynamics.

Maria L Alvarellos1, Ellen M McDonagh, Sephalie Patel, Howard L McLeod, Russ B Altman, Teri E Klein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26398623      PMCID： PMC4631707          DOI： 10.1097/FPC.0000000000000170

Source DB:  PubMed          Journal:  Pharmacogenet Genomics        ISSN： 1744-6872            Impact factor:   2.089


× No keyword cloud information.
  61 in total

1.  Identification of the Arg1086His mutation in the alpha subunit of the voltage-dependent calcium channel (CACNA1S) in a North American family with malignant hyperthermia.

Authors:  S L Stewart; K Hogan; H Rosenberg; J E Fletcher
Journal:  Clin Genet       Date:  2001-03       Impact factor: 4.438

2.  Next-generation DNA sequencing of a Swedish malignant hyperthermia cohort.

Authors:  M Broman; I Kleinschnitz; J E Bach; S Rost; G Islander; C R Müller
Journal:  Clin Genet       Date:  2014-10-21       Impact factor: 4.438

3.  Naturally occurring mutation Leu307Pro of human butyrylcholinesterase in the Vysya community of India.

Authors:  Indumathi Manoharan; Stacy Wieseler; Paul G Layer; Oksana Lockridge; Rathnam Boopathy
Journal:  Pharmacogenet Genomics       Date:  2006-07       Impact factor: 2.089

4.  Heat- and anesthesia-induced malignant hyperthermia in an RyR1 knock-in mouse.

Authors:  Mihail G Chelu; Sanjeewa A Goonasekera; William J Durham; Wei Tang; John D Lueck; Joyce Riehl; Isaac N Pessah; Pumin Zhang; Meenakshi B Bhattacharjee; Robert T Dirksen; Susan L Hamilton
Journal:  FASEB J       Date:  2005-11-11       Impact factor: 5.191

5.  Genotyping the butyrylcholinesterase in patients with prolonged neuromuscular block after succinylcholine.

Authors:  Soledad Levano; Hans Ginz; Martin Siegemund; Miodrag Filipovic; Evgueni Voronkov; Albert Urwyler; Thierry Girard
Journal:  Anesthesiology       Date:  2005-03       Impact factor: 7.892

6.  Enhanced response to caffeine and 4-chloro-m-cresol in malignant hyperthermia-susceptible muscle is related in part to chronically elevated resting [Ca2+]i.

Authors:  José R López; Nancy Linares; Isaac N Pessah; Paul D Allen
Journal:  Am J Physiol Cell Physiol       Date:  2004-11-10       Impact factor: 4.249

7.  Anesthesia and Duchenne or Becker muscular dystrophy: review of 117 anesthetic exposures.

Authors:  Leal G Segura; Jessica D Lorenz; Toby N Weingarten; Federica Scavonetto; Katarina Bojanić; Duygu Selcen; Juraj Sprung
Journal:  Paediatr Anaesth       Date:  2013-08-06       Impact factor: 2.556

Review 8.  Mammalian nicotinic acetylcholine receptors: from structure to function.

Authors:  Edson X Albuquerque; Edna F R Pereira; Manickavasagom Alkondon; Scott W Rogers
Journal:  Physiol Rev       Date:  2009-01       Impact factor: 37.312

Review 9.  Store-operated Ca2+ entry in muscle physiology and diseases.

Authors:  Zui Pan; Marco Brotto; Jianjie Ma
Journal:  BMB Rep       Date:  2014-02       Impact factor: 4.778

10.  The role of CACNA1S in predisposition to malignant hyperthermia.

Authors:  Danielle Carpenter; Christopher Ringrose; Vincenzo Leo; Andrew Morris; Rachel L Robinson; P Jane Halsall; Philip M Hopkins; Marie-Anne Shaw
Journal:  BMC Med Genet       Date:  2009-10-13       Impact factor: 2.103
View more
  9 in total

Review 1.  The Outlier in All of Us: Why Implementing Pharmacogenomics Could Matter for Everyone.

Authors:  P H O'Donnell; K Danahey; M J Ratain
Journal:  Clin Pharmacol Ther       Date:  2016-02-15       Impact factor: 6.875

2.  CYP2B6*6 or Not CYP2B6*6-That Remains a Question for Precision Medicine and Ketamine!

Authors:  Scott D Cook-Sather; Peter C Adamson; Jin Li; Hakon Hakonarson
Journal:  Anesthesiology       Date:  2016-12       Impact factor: 7.892

Review 3.  Structural Modification in Anesthetic Drug Development for Prodrugs and Soft Drugs.

Authors:  Chaoyi Deng; Jin Liu; Wensheng Zhang
Journal:  Front Pharmacol       Date:  2022-07-01       Impact factor: 5.988

4.  Genetic Testing for BCHE Variants Identifies Patients at Risk of Prolonged Neuromuscular Blockade in Response to Succinylcholine.

Authors:  Guang-Dan Zhu; Eric Dawson; Angela Huskey; Ronald J Gordon; Andria L Del Tredici
Journal:  Pharmgenomics Pers Med       Date:  2020-09-30

Review 5.  PharmGKB summary: very important pharmacogene information for RYR1.

Authors:  Maria L Alvarellos; Ronald M Krauss; Russell A Wilke; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2016-03       Impact factor: 2.089

Review 6.  Pharmacogenomic considerations for medications in the perioperative setting.

Authors:  Ellie H Jhun; Jeffrey L Apfelbaum; David M Dickerson; Sajid Shahul; Randall Knoebel; Keith Danahey; Mark J Ratain; Peter H O'Donnell
Journal:  Pharmacogenomics       Date:  2019-07       Impact factor: 2.638

7.  PharmGKB summary: very important pharmacogene information for CACNA1S.

Authors:  Katrin Sangkuhl; Robert T Dirksen; Maria L Alvarellos; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2020-02       Impact factor: 2.000

8.  Potential role of pharmacogenomics testing in the setting of enhanced recovery pathways after surgery.

Authors:  Hamdy Awad; Ahmed Ahmed; Richard D Urman; Nicoleta Stoicea; Sergio D Bergese
Journal:  Pharmgenomics Pers Med       Date:  2019-07-26

9.  Comparison of Rocuronium with Succinylcholine for Rapid Sequence Induction Intubation in the Emergency Department: A Retrospective Study at a Single Center in China.

Authors:  Gui Li; Lin Cheng; Jianke Wang
Journal:  Med Sci Monit       Date:  2021-01-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.